HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Antitumor effects of novel immunoactive peptides, FK-156 and its synthetic derivatives.

Abstract
Effects produced by intratumor or systemic application of FK-156 and its synthetic derivatives on the syngeneic P388-DBA/2 mouse system were investigated. Among 21 compounds tested, FK-156, FK-565, FR-46758, FR-48217, FR-46091 and FR-47920 substantially suppressed tumor growth when directly injected into a tumor mass and further experiments showed that FK-156, FK-565 and FR-46758 were effective even when administered subcutaneously into site remote from tumor. The mechanisms of growth inhibition are strongly suggested to be host mediated, because these three compounds have remarkably low cytotoxicity against P388 cells in vitro. A single dose of FK-565, however, markedly decreased body weight in healthy DBA/2 mice, whereas FK-156 and FR-46758 did not. These results indicate the superiority of FK-156 and FR-46758 as immunotherapeutic agents over FK-565 with respect to their safety for treatment of cancer. Although significant life-span prolongation could not be seen in the two-injection regimen of six compounds in either system, systemic multiple injections of FK-156 and FR-46758 provided a statistically significant increase in the median survival time of P388 tumor bearing mice.
AuthorsS Izumi, K Nakahara, T Gotoh, S Hashimoto, T Kino, M Okuhara, H Aoki, H Imanaka
JournalThe Journal of antibiotics (J Antibiot (Tokyo)) Vol. 36 Issue 5 Pg. 566-74 (May 1983) ISSN: 0021-8820 [Print] JAPAN
PMID6192122 (Publication Type: Journal Article)
Chemical References
  • Adjuvants, Immunologic
  • Amino Acids, Diamino
  • Antineoplastic Agents
  • Diaminopimelic Acid
  • FK 156
  • Interferons
Topics
  • Adjuvants, Immunologic (administration & dosage, therapeutic use, toxicity)
  • Amino Acids, Diamino (therapeutic use)
  • Animals
  • Antineoplastic Agents (administration & dosage, therapeutic use, toxicity)
  • Diaminopimelic Acid (administration & dosage, analogs & derivatives, therapeutic use, toxicity)
  • Female
  • Interferons (therapeutic use)
  • Mice
  • Mice, Inbred DBA
  • Neoplasms, Experimental (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: